T3 Companies’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

T3 Companies’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$615K	Hold	18,900	–	–	0.66%	28
2026 Q1	$565K	Hold	18,900	–	–	0.74%	27
2025 Q4	$548K	Buy	+18,900	New	+$379K	0.68%	31

Other funds holding YARW

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

MLA

MB, Levis & Associates Center Valley, Pennsylvania $271M AUM 15.56% 1-Year Est. Return

FWA

Flagship Wealth Advisors Wakefield, Massachusetts $447M AUM 25.09% 1-Year Est. Return

T3 Companies's YARW Position: Q2 2026 in Review

T3 Companies held its Yarrow Bioscience, Inc. Common Stock (YARW) position steady in Q2 2026 at 18,900 shares worth $615K. The position accounts for 0.66% of the portfolio, ranked #28.

T3 Companies first reported a position in YARW in Q4 2025 and has held it in 3 quarters since. 4 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

T3 Companies held 18,900 shares of Yarrow Bioscience, Inc. Common Stock worth $615K as of Q2 2026.
T3 Companies left its Yarrow Bioscience, Inc. Common Stock share count unchanged in Q2 2026.
Yarrow Bioscience, Inc. Common Stock made up 0.66% of T3 Companies's portfolio in Q2 2026, its #28 holding.
T3 Companies first reported a position in Yarrow Bioscience, Inc. Common Stock in Q4 2025 and has held it in 3 quarters since.
4 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q2 2026.

Based on T3 Companies's 13F filing for Q2 2026, filed 27 Jul 2026.